Epstein Barr Virus - Early Antigen (EBV-EA) Antibody Test Kit

... is a formulation of iopamidol ... by oral administration or, where necessary, ... considerable improvement in the radiological exploration ... traditional contrast media. Thanks to its ...

... dimeglumine) is a paramagnetic MRI contrast agent. ... gadobenate, a chelating agent that forms a ... ion. It is salified with meglumine forming ... all the physico-chemical features typical of gadolinium ...

... GastroMARK (generic name: ferumoxsil) is Advanced ... distinguish the loops of the bowel from ... of organs and tissues in the abdomen ... organs and tissues cannot be easily distinguished ...

... Up to 20% of the ... the U.S. are suboptimal. Activated DEFINITY ... clearer images of the heart than ... activated DEFINITY improves diagnostic quality for ...

(Date:7/29/2010)... NY, July 30, 2010Thirty million women will benefit from ... either through new or strengthened insurance coverage, according to ... first analysis of its kind, the authors report that ... to health costs that women now experience by subsidizing ... women, and strengthening existing coverage for 14.5 million women ...

(Date:7/29/2010)... Researchers seeking to learn more about stroke by studying how ... week releasing new findings that they hope will aid in ... , The Japanese team is reporting in a ... they are optimistic that inhibiting a protein found on the ... irregular blood clotting and the spread of certain cancers throughout ...

(Date:7/29/2010)... the first time a cell-of-origin for human prostate ... predictive and diagnostics tools and the development of ... disease. , The researchers, from UCLA,s Jonsson Comprehensive ... benign prostate tissue could become human prostate cancer ... that bucks conventional wisdom. It had been widely ...

(Date:7/29/2010)... and Drug Administration (FDA) received reports of malignancies in ... concerns of an associated risk and prompting an investigation. ... reports of malignancy in children using infliximab, etanercept, and ... issue of Arthritis & Rheumatism , a journal ... FDA has approved 3 TNF blockers for use in ...

(Date:7/29/2010)... brain cells remain diverse and "fit" enough for storing ... Neuron , a new study led by Dr. Inna ... Aviv University describes what makes some memories stick. , ... that occurs in the brain, which could be the ... can generate, the new study has found. The understanding ...

... Call Today at 8 a.m. EDT, CARLSBAD, ... Inc. (Nasdaq: ISIS ) and Genzyme Corp. ... has provided guidance regarding approval,requirements for mipomersen. The ... acceptable surrogate endpoint for accelerated,approval of mipomersen for ...

... April 25 Universal,Health Realty Income Trust (NYSE: ... 31, 2008, net income was $4.2 million, or $.35 ... per diluted share, during the,same quarter in the prior ... of 2008 was increased depreciation expense of $329,000,or $.03 ...

... Today, on World Malaria,Day, the American Red Cross ... a robust global response to this deadly disease., ... approximately 300 million people, mostly children in Africa. More,than ... disease., Since 2001, the American Red Cross and ...

... aging ... friendship and fun, FULLERTON, Calif., April 25 Women from coast-to-coast,and ... Hat Society (RHS), founded 10 years ago today, perceptions began,to change. In ... hats and purple outfits in the spirit of having fun at 50 ...

... United Healthcare,Workers - West and Motion Picture & Television ... on a new five-year contract, which,provides stable and predictable ... MPTF Hospital and Health Centers through October,2012. The agreement ... to its membership, and ratification is expected by the,end ...

... breast cancers that depend on hormones and those ... April 25th in the open-access journal PLoS Genetics. ... cancers, which usually require treatment with surgery and ... as hormone independent breast cancers, which are treated ...

(Date:7/29/2010)... Vermillion, Inc. (Nasdaq: VRML ), a molecular diagnostics company, will host ... issuance of Q2 financial results on Monday, August 16, 2010 . ... Conference Call Information ... To access the ... United States and Canada or +1 212 231 2901 ...

(Date:7/29/2010)... response to the agreement announced that CVS Caremark would provide pharmacy ... the National Community Pharmacists Association (NCPA) issued the following statement from ... H. Harmison , PD: , ... (Logo: http://photos.prnewswire.com/prnh/20100106/DC33253LOGO ) , ... (Logo: http://www.newscom.com/cgi-bin/prnh/20100106/DC33253LOGO ) , ...

(Date:7/29/2010)... , July 29 ... from a Phase Ib/II clinical trial in ... unique, investigational new drug for the treatment ... endpoint demonstrating that ITI-007 was safe and ... addition, several exploratory endpoints were evaluated. Treatment ...